Your browser doesn't support javascript.
loading
A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.
Kiesgen, Stefan; Liebers, Nora; Cremer, Martin; Arnold, Ulrich; Weber, Tobias; Keller, Armin; Herold-Mende, Christel; Dyckhoff, Gerhard; Jäger, Dirk; Kontermann, Roland E; Arndt, Michaela A E; Krauss, Jürgen.
Afiliação
  • Kiesgen S; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Liebers N; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Cremer M; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Arnold U; Institute of Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle, Germany.
  • Weber T; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Keller A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany Molecular Cell Biology Group, ENT Department, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
  • Dyckhoff G; Molecular Cell Biology Group, ENT Department, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
  • Jäger D; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany.
  • Kontermann RE; Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany.
  • Arndt MA; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany Present address: Immunotherapy Program, National Center for Tumor Diseases, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heid
  • Krauss J; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Im Neuenheimer Feld 460, 69120 Heidelberg, Germany juergen.krauss@nct-heidelberg.de.
Protein Eng Des Sel ; 27(10): 331-7, 2014 Oct.
Article em En | MEDLINE | ID: mdl-25301960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleases / Proteínas Recombinantes de Fusão / Vírus da Dengue / Anticorpos de Cadeia Única / Receptores ErbB / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleases / Proteínas Recombinantes de Fusão / Vírus da Dengue / Anticorpos de Cadeia Única / Receptores ErbB / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article